1296 related articles for article (PubMed ID: 19387125)
21. Human papillomavirus testing for primary cervical cancer screening.
Grce M; Davies P
Expert Rev Mol Diagn; 2008 Sep; 8(5):599-605. PubMed ID: 18785808
[TBL] [Abstract][Full Text] [Related]
22. Women's reactions to HPV diagnosis: insights from in-depth interviews.
Perrin KK; Daley EM; Naoom SF; Packing-Ebuen JL; Rayko HL; McFarlane M; McDermott RJ
Women Health; 2006; 43(2):93-110. PubMed ID: 17000613
[TBL] [Abstract][Full Text] [Related]
23. Midadult women's attitudes about receiving the prophylactic human papillomavirus vaccine.
Ferris DG; Waller JL; Owen A; Smith J
J Low Genit Tract Dis; 2007 Jul; 11(3):166-72. PubMed ID: 17596762
[TBL] [Abstract][Full Text] [Related]
24. Attitudes toward HPV testing: interview findings from a random sample of women in Ontario, Canada.
Brown L; Ritvo P; Howlett R; Cotterchio M; Matthew A; Rosen B; Murphy J; Mai V
Health Care Women Int; 2007 Oct; 28(9):782-98. PubMed ID: 17907007
[TBL] [Abstract][Full Text] [Related]
25. Eligibility and willingness of young Icelandic women to participate in a HPV vaccination trial.
Gudmundsdóttir T; Tryggvadóttir L; Allende M; Mast TC; Briem H; Sigurdsson K
Acta Obstet Gynecol Scand; 2003 Apr; 82(4):345-50. PubMed ID: 12716319
[TBL] [Abstract][Full Text] [Related]
26. Psychological impact of human papillomavirus testing in women with borderline or mildly dyskaryotic cervical smear test results: cross sectional questionnaire study.
Maissi E; Marteau TM; Hankins M; Moss S; Legood R; Gray A
BMJ; 2004 May; 328(7451):1293. PubMed ID: 15166066
[TBL] [Abstract][Full Text] [Related]
27. Epidemiology of human papillomavirus infection and cervical cancer and future perspectives in Hong Kong, Singapore and Taiwan.
Tay SK; Ngan HY; Chu TY; Cheung AN; Tay EH
Vaccine; 2008 Aug; 26 Suppl 12():M60-70. PubMed ID: 18945415
[TBL] [Abstract][Full Text] [Related]
28. Psychological burden of testing positive for high-risk human papillomavirus on women with atypical cervical cytology: a prospective study.
Kwan TT; Cheung AN; Lo SS; Lee PW; Tam KF; Chan KK; Ngan HY
Acta Obstet Gynecol Scand; 2011 May; 90(5):445-51. PubMed ID: 21306349
[TBL] [Abstract][Full Text] [Related]
29. Exploring the acceptability of two self-sampling devices for human papillomavirus testing in the cervical screening context: a qualitative study of Muslim women in London.
Szarewski A; Cadman L; Ashdown-Barr L; Waller J
J Med Screen; 2009; 16(4):193-8. PubMed ID: 20054094
[TBL] [Abstract][Full Text] [Related]
30. Screening for cervical cancer among Israeli lesbian women.
Ben-Natan M; Adir O
Int Nurs Rev; 2009 Dec; 56(4):433-41. PubMed ID: 19930071
[TBL] [Abstract][Full Text] [Related]
31. The psychological impact of illness among women experiencing human papillomavirus-related illness or screening interventions.
Wang KL; Jeng CJ; Yang YC; Chen CA; Cheng WF; Chen TC; Mast TC; Wang YC; Hsieh CY
J Psychosom Obstet Gynaecol; 2010 Mar; 31(1):16-23. PubMed ID: 20121461
[TBL] [Abstract][Full Text] [Related]
32. HPV testing versus repeat Pap testing for the management of a minor abnormal Pap smear: evaluation of a decision aid to support informed choice.
McCaffery KJ; Irwig L; Chan SF; Macaskill P; Barratt A; Lewicka M; Clarke J; Weisberg E
Patient Educ Couns; 2008 Dec; 73(3):473-9, 481. PubMed ID: 18757164
[TBL] [Abstract][Full Text] [Related]
33. Cervical cancer screening among South Asian women in Canada: the role of education and acculturation.
Gupta A; Kumar A; Stewart DE
Health Care Women Int; 2002 Feb; 23(2):123-34. PubMed ID: 11868960
[TBL] [Abstract][Full Text] [Related]
34. Knowledge, attitudes, and practice related to cervical cancer screening among Kuwaiti women.
Al Sairafi M; Mohamed FA
Med Princ Pract; 2009; 18(1):35-42. PubMed ID: 19060489
[TBL] [Abstract][Full Text] [Related]
35. A notable accessory screening program for detection of cervical intraepithelial neoplasia.
Tsai HT; Tsai YM; Yang SF; Lee CH; Lin LY; Lee S; Wu MT
Pathol Biol (Paris); 2009 Sep; 57(6):477-82. PubMed ID: 18586410
[TBL] [Abstract][Full Text] [Related]
36. HPV vaccine acceptability in Ghana, West Africa.
Coleman MA; Levison J; Sangi-Haghpeykar H
Vaccine; 2011 May; 29(23):3945-50. PubMed ID: 21481327
[TBL] [Abstract][Full Text] [Related]
37. Women's experiences of repeated HPV testing in the context of cervical cancer screening: a qualitative study.
Waller J; McCaffery K; Kitchener H; Nazroo J; Wardle J
Psychooncology; 2007 Mar; 16(3):196-204. PubMed ID: 16858719
[TBL] [Abstract][Full Text] [Related]
38. Cervical cytology in vulnerable pregnant women.
Loomis DM; Pastore PA; Rejman K; Gutierrez KL; Bethea B
J Am Acad Nurse Pract; 2009 May; 21(5):287-94. PubMed ID: 19432913
[TBL] [Abstract][Full Text] [Related]
39. Knowledge and beliefs about cervical cancer and human papillomavirus among Taiwanese undergraduate women.
Hsu YY; Cheng YM; Hsu KF; Fetzer SJ; Chou CY
Oncol Nurs Forum; 2011 Jul; 38(4):E297-304. PubMed ID: 21708525
[TBL] [Abstract][Full Text] [Related]
40. Acceptability of self-collection of specimens for HPV DNA testing in an urban population.
Anhang R; Nelson JA; Telerant R; Chiasson MA; Wright TC
J Womens Health (Larchmt); 2005 Oct; 14(8):721-8. PubMed ID: 16232104
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
